| Dexamethasone in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 384 (8), 693-704, 2021 | 2805 | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1717* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 445* | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 320 | 2021 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 230 | 2022 |
| Physical activity of UK adults with chronic disease: cross-sectional analysis of accelerometer-measured physical activity in 96 706 UK Biobank participants J Barker, K Smith Byrne, A Doherty, C Foster, K Rahimi, R Ramakrishnan, ... International Journal of Epidemiology 48 (4), 1167-1174, 2019 | 161 | 2019 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 113 | 2021 |
| Awake prone positioning in COVID-19 D Koeckerling, J Barker, NL Mudalige, O Oyefeso, D Pan, M Pareek, ... Thorax 75 (10), 833-834, 2020 | 100 | 2020 |
| COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life J Barker, O Oyefeso, D Koeckerling, NL Mudalige, D Pan Thorax, 2020 | 76 | 2020 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 47 | 2022 |
| A need for prone position CPR guidance for intubated and non-intubated patients during the COVID-19 pandemic J Barker, D Koeckerling, R West Resuscitation 151, 135-136, 2020 | 36 | 2020 |
| Blood transfusion strategies and ECMO during the COVID-19 pandemic D Koeckerling, D Pan, NL Mudalige, O Oyefeso, J Barker The Lancet Respiratory Medicine 8 (5), e40, 2020 | 28 | 2020 |
| Machine learning in sudden cardiac death risk prediction: a systematic review J Barker, X Li, S Khavandi, D Koeckerling, A Mavilakandy, C Pepper, ... Europace 24 (11), 1777-1787, 2022 | 22 | 2022 |
| Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open … O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 401 (10387), 1499-1507, 2023 | 21 | 2023 |
| Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis D Koeckerling, PF Raguindin, L Kastrati, S Bernhard, J Barker, ... European Heart Journal 44 (11), 935-950, 2023 | 18 | 2023 |
| Effect of serial awake prone positioning on oxygenation in patients admitted to intensive care with COVID-19 J Barker, D Pan, D Koeckerling, AJ Baldwin, R West Postgraduate medical journal 98 (1159), 360-364, 2022 | 17 | 2022 |
| The need for improved discharge criteria for hospitalised patients with COVID-19—implications for patients in long-term care facilities S Sze, D Pan, CML Williams, J Barker, JS Minhas, CJ Miller, JW Tang, ... Age and ageing 50 (1), 16-20, 2021 | 14 | 2021 |
| Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet Diabetes & Endocrinology 11 (12), 905-914, 2023 | 12 | 2023 |
| The new UK SARS-CoV-2 variant and lockdown–causes and consequences D Pan, NL Mudalige, S Sze, D Koeckerling, O Oyefeso, J Barker, ... Clinical Medicine 21 (3), e295-e299, 2021 | 11 | 2021 |
| NEWS2 system requires modification to identify deteriorating patients with COVID-19. N TY LIM, D Pan, J Barker Clinical Medicine 20 (4), 2020 | 11 | 2020 |
Daniel PanDepartment of Respiratory Sciences, University of Leicester在 leicester.ac.uk 的电子邮件经过验证
